CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial

View at publisher Summarise with VIRAT
Authors: Jessica S.W. Borgers, Cheng-Chang Wu, T. Medina, Claire M Muckle, Elizabeth N. Katsnelson, Phaedra A. Whitty, Luke Mantle, Sapna Pradyuman Patel, D. Gao, Kimberly Rae Jordan, William Allen Robinson, Richard P. Tobin
+2 more Kasey L. Couts, Martin D. McCarter
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cutaneous Melanoma Detection and Management Cancer Immunotherapy and Biomarkers Epigenetics and DNA Methylation

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN